Vivo Opportunity LLC 13D and 13G filings for Avadel Pharmaceuticals plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-13 5:42 pm Sale |
2022-12-31 | 13G | Avadel Pharmaceuticals plc AVDL |
Vivo Opportunity LLC | 2,251,663 3.600% |
-149,613 (-6.23%) |
Filing |
| 2022-02-11 5:21 pm Sale |
2021-12-31 | 13G | Avadel Pharmaceuticals plc AVDL |
Vivo Opportunity LLC | 2,401,276 4.100% |
-481,548 (-16.70%) |
Filing |